Acceleration of Bone Regeneration Induced by a Soft-Callus Mimetic Material.
Alessia LongoniLizette UtomoAbbie RobinsonRiccardo LevatoAntoine J W P RosenbergDebby GawlittaPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2021)
Clinical implementation of endochondral bone regeneration (EBR) would benefit from the engineering of devitalized cartilaginous constructs of allogeneic origins. Nevertheless, development of effective devitalization strategies that preserves extracellular matrix (ECM) is still challenging. The aim of this study is to investigate EBR induced by devitalized, soft callus-mimetic spheroids. To challenge the translatability of this approach, the constructs are generated using an allogeneic cell source. Neo-bone formation is evaluated in an immunocompetent rat model, subcutaneously and in a critical size femur defect. Living spheroids are used as controls. Also, the effect of spheroid maturation towards hypertrophy is evaluated. The devitalization procedure successfully induces cell death without affecting ECM composition or bioactivity. In vivo, a larger amount of neo-bone formation is observed for the devitalized chondrogenic group both ectopically and orthotopically. In the femur defect, accelerated bone regeneration is observed in the devitalized chondrogenic group, where defect bridging is observed 4 weeks post-implantation. The authors' results show, for the first time, a dramatic increase in the rate of bone formation induced by devitalized soft callus-mimetics. These findings pave the way for the development of a new generation of allogeneic, "off-the-shelf" products for EBR, which are suitable for the treatment of every patient.
Keyphrases
- bone regeneration
- extracellular matrix
- stem cell transplantation
- bone marrow
- cell death
- mesenchymal stem cells
- hematopoietic stem cell
- high dose
- healthcare
- single cell
- primary care
- case report
- cell therapy
- minimally invasive
- body composition
- finite element
- quality improvement
- signaling pathway
- cell cycle arrest
- replacement therapy
- gestational age
- smoking cessation